Dear Colleagues from the ESC Working Group on Atherosclerosis and Vascular Biology. We hope you are enjoying the summer!
If you don’t have anything to read during the summer, here are some interesting articles to consider:
- Translatome profiling reveals Itih4 as a novel smooth muscle cell–specific gene in atherosclerosis, Aarthi Ravindran and others, Cardiovascular Research, Volume 120, Issue 8, May 2024, Pages 869–882
- Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways, Srividya Velagapudi and others, Cardiovascular Research, Volume 120, Issue 5, April 2024, Pages 476–489
If you want more, access all our recommended readings here.
One of the group’s tasks is to promote scientific interactions on our topic and it is wonderful to share some memories of our members recently networking with the Swiss Society of Cardiology in Lausanne.
… And also at the European Society of Atherosclerosis 60th anniversary meeting in Lyon!
More exciting meetings are approaching in addition to the ESC Congress in London, such as the 19th Biennial Meeting of the International Society for Applied Cardiovascular Biology, ISACB 2024, in Vienna 2024 (5-8 October 2024):
Our LinkedIn group #AtheroMatters is always eager to receive more posts and stimulate interactions so please feel free to write there and share your news to our community.
If you (or someone you know) are looking for a job, there is an exciting opportunity at the University of Leuven, Belgium:
Research professor in Atherosclerosis & Therapeutic Approaches (https://www.kuleuven.be/personeel/jobsite/jobs/60311816?lang=en)
This newsletter is, once again, for YOU, so please do recommend papers, conferences, jobs, etc. by sending content to us (Isabel.Goncalves@med.lu.se or Lutgens.Esther@mayo.edu) subject: WG Atherosclerosis Vascular Biology.
We are looking forward to meeting you at ESC Congress in London from 30 August to 2 September 2024!
Isabel and Esther
On behalf of the communication team of the Working Group on Atherosclerosis and Vascular Biology
Our mission: To reduce the burden of cardiovascular disease.